tiprankstipranks
Trending News
More News >
MedCap AB (DE:61MA)
FRANKFURT:61MA
Germany Market
Advertisement

MedCap AB (61MA) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
16Bullish
4Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
MedCap AB’s (61MA) Moving Averages Convergence Divergence (MACD) indicator is 0.18, suggesting MedCap AB is a Buy.
MedCap AB’s (61MA) 20-Day exponential moving average is 55.89, while MedCap AB’s (61MA) share price is €56.5, making it a Buy.
MedCap AB’s (61MA) 50-Day exponential moving average is 53.33, while MedCap AB’s (61MA) share price is €56.5, making it a Buy.

MedCap AB (61MA) Pivot Points

Sep 15, 2025, 06:37 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
55.70
55.70
55.70
55.70
55.70
55.70
55.70
Fibonacci
55.70
55.70
55.70
55.70
55.70
55.70
55.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MedCap AB (61MA) Moving Averages

Sep 15, 2025, 06:37 AM
Period
Simple
Exponential
MA5
55.70Buy
55.83Buy
MA10
55.34Buy
55.77Buy
MA20
56.34Buy
55.89Buy
MA50
54.27Buy
53.33Buy
MA100
46.82Buy
49.05Buy
MA200
43.00Buy
46.27Buy
MedCap AB’s (61MA) 10-Day exponential moving average is 55.77, while MedCap AB’s (61MA) share price is €56.5, making it a Buy.
MedCap AB’s (61MA) 100-Day exponential moving average is 49.05, while MedCap AB’s (61MA) share price is €56.5, making it a Buy.
MedCap AB’s (61MA) stock price is €56.5 and MedCap AB’s (61MA) 50-day simple moving average is 54.27, creating a Buy signal.
MedCap AB’s (61MA) stock price is €56.5 and MedCap AB’s (61MA) 100-day simple moving average is 46.82, creating a Buy signal.
MedCap AB’s (61MA) stock price is €56.5 and MedCap AB’s (61MA) 200-day simple moving average is 43.00, creating a Buy signal.

MedCap AB (61MA) Technical Indicators

Sep 15, 2025, 06:37 AM
Name
Value
Implied Action
RSI (14)
54.88
Neutral
STOCH (9,6)
97.44
Sell
STOCHRSI (14)
36.97
Neutral
MACD (12,26)
0.18
Buy
ADX (14)
16.76
Buy
Williams %R
-41.18
Buy
CCI (14)
8.72
Neutral
ATR (14)
0.75
-
Ultimate Oscillator
65.76
Neutral
ROC
-4.72
Sell
MedCap AB’s (61MA) Relative Strength Index (RSI) is 54.88, creating a Neutral signal.
MedCap AB’s (61MA) Trend Strength Indicator (ADX) is 16.76, creating a Buy signal.
MedCap AB’s (61MA) Commodity Channel Index (CCI) is 8.72, creating a Neutral signal.
MedCap AB’s (61MA) Price Rate of Change (ROC) is -4.72, creating a Sell signal.

FAQ

Is 61MA a Buy, Hold, or Sell?
Based on 61MA’s technical indicators, 61MA is a Strong Buy.
    What is 61MA’s RSI (14)?
    61MA’s RSI (14) is 54.88, which suggests 61MA is a Neutral.
      What is 61MA’s MACD?
      61MA’s MACD is 0.18, which suggests 61MA is a Buy.
        What is 61MA’s 5-day moving average?
        61MA’s 5-day moving average is 55.70, which suggests 61MA is a Buy.
          What is 61MA’s 20-day moving average?
          61MA 20-day moving average is 56.34, which suggests 61MA is a Buy.
            What is 61MA’s 50-day moving average?
            61MA’s 50-day moving average is 54.27, which suggests 61MA is a Buy.
              What is 61MA’s 200-day moving average?
              61MA’s 200-day moving average is 43.00, which suggests 61MA is a Buy.
                What is 61MA’s Williams % R (14)?
                61MA’s Williams % R (14) is -41.18, which suggests 61MA is a Buy.
                  What is 61MA’s CCI (14)?
                  61MA’s CCI (14) is 8.72, which suggests 61MA is a Neutral.
                    What is the share price of MedCap AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis